Provided by Tiger Fintech (Singapore) Pte. Ltd.

Scilex Holding Company

6.16
-0.1500-2.38%
Volume:64.72K
Turnover:405.93K
Market Cap:42.82M
PE:-0.29
High:6.47
Open:6.30
Low:6.08
Close:6.31
Loading ...

Scilex Holding Full Year 2024 Earnings: EPS Beats Expectations

Simply Wall St.
·
02 Apr

Scilex Holding Is Maintained at Buy by D. Boral Capital

Dow Jones
·
02 Apr

Scilex Holding Company Has Appealed Lower Court Decision to the U.S. Court of Appeals for the Federal Circuit in Washington, DC and Will Continue to Vigorously Pursue its Infringement Action Against Aveva

GlobeNewswire
·
27 Mar

Denali Capital Acquisition Pushes Merger Deadline With Extra Funding

MT Newswires Live
·
12 Mar

Scilex Holding Company Announces Change in Record Date for its Previously Announced Dividend of Preferred Stock Exchangeable for up to 10% of Scilex’s Ownership Interest in Semnur Pharmaceuticals, Inc., its Wholly Owned Subsidiary from January 28, 2025 to April 11, 2025

GlobeNewswire
·
10 Mar

Breakeven Is Near for Scilex Holding Company (NASDAQ:SCLX)

Simply Wall St.
·
04 Mar

BRIEF-Scilex Holding Says Terminates Sales Agreement With B. Riley, Cantor Fitzgerald, H.C. Wainwright Effective March 5

Reuters
·
04 Mar

Scilex Holding Co - Terminates Sales Agreement With B. Riley, Cantor Fitzgerald, H.c. Wainwright Effective March 5

THOMSON REUTERS
·
04 Mar

Scilex Holding Is Maintained at Buy by D. Boral Capital

Dow Jones
·
28 Feb

Scilex Holding Co - Scilex Pharma Enters License Agreement With Royaltyvest

THOMSON REUTERS
·
28 Feb

Scilex Holding Co - Royaltyvest Granted Exclusive Rights to Lido Products Outside U.S.

THOMSON REUTERS
·
28 Feb

Scilex says bankruptcy court extends lockup period on shares of Scilex dividend

TIPRANKS
·
31 Jan

Scilex Holding Company Announces That the U.S. Bankruptcy Court Has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to Its Stockholders as a Dividend to April 14, 2025

THOMSON REUTERS
·
31 Jan

Scilex Holding Faces Financial Strain Amid Form S-3 Ineligibility Crisis

TIPRANKS
·
23 Jan

Scilex announces U.S. FDA acknowledged submission of SNDA for ELYXYB

TIPRANKS
·
22 Jan

Scilex Holding Company Announces That the U.S. FDA Has Acknowledged the Submission of Our Supplemental New Drug Application for Elyxyb® in Acute Pain Indication

THOMSON REUTERS
·
22 Jan

Scilex Regains Compliance With Nasdaq Requirement for Continued Listing

MT Newswires Live
·
22 Jan

Scilex regains compliance with Nasdaq listing rules

TIPRANKS
·
22 Jan

Scilex Holding Company Announces That It Regains Nasdaq Compliance Under Listing Rule 5250(C)(1)

THOMSON REUTERS
·
22 Jan

Scilex Holding Company Announces Extension of the Maturity Date of Its Secured Promissory Note Issued to Oramed Pharmaceuticals Inc. to December 31, 2025

THOMSON REUTERS
·
21 Jan